4.4600
-0.1800
(-3.88%)
At close: January 31 at 4:00:01 PM EST
4.4600
0.00
(0.00%)
After hours: January 31 at 5:25:03 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| GORDON CARL L Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 16, 2024 | -- |
| KURIAKOSE EMIL T. Officer | Sale | Jan 2, 2025 | 54,269 |
| LU HONGBO B Director | Purchase | Sep 12, 2024 | -- |
| ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Sale | Jul 16, 2024 | -- |
| QUIGLEY JILL M. Director | Sale | Jan 6, 2025 | 0 |
| QUIRK ERIN M.D. Officer | Stock Award(Grant) | Jan 23, 2024 | 75,000 |
| SUNDARAM SENTHIL VEL Chief Executive Officer | Purchase | May 31, 2023 | 9,770 |
| VIGNOLA MARK J. Chief Financial Officer | Sale | Jan 6, 2025 | 74,752 |
| VIVO OPPORTUNITY LLC Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 3, 2024 | -- |
| YOON SEOKHO BRYAN Chief Operating Officer | Purchase | May 31, 2024 | 91,940 |
Related Tickers
ALT Altimmune, Inc.
6.64
-5.14%
GPCR Structure Therapeutics Inc.
29.97
-1.15%
ETNB 89bio, Inc.
9.60
-0.41%
CRDF Cardiff Oncology, Inc.
4.0300
+1.51%
VSTM Verastem, Inc.
6.08
-2.25%
MDGL Madrigal Pharmaceuticals, Inc.
334.80
-1.03%
ARVN Arvinas, Inc.
17.61
-1.57%
KYMR Kymera Therapeutics, Inc.
39.59
-2.13%
IOVA Iovance Biotherapeutics, Inc.
5.85
-5.80%
URGN UroGen Pharma Ltd.
11.01
-3.00%